ROARABLE
FREE $100K
Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Health Care / PRVA / news
AVAH (65) ADUS (74) WGS (47) OPCH (74) ⌘ Pro Terminal →

Why PRVA Stock slipped -0.93% Today — RQD Quant Desk Flash

$21.28 -0.93% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $21.20

Privia Health Group Inc. (PRVA) carries a Roarable Rating of D+ (Sell) with 53/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D+ • SELL / AVOID Cap $2.74B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on PRVA Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is PRVA stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Privia Health Group Inc. (NASDAQ: PRVA) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 53/100 at a spot price of $21.28 (-0.93% 1D, market cap $2.74B). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 10/20. Across 1016 tracked Health Care issuers, PRVA ranks #230 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does PRVA compare to AVAH and ADUS in the Health Care sector?
▼

Within the Health Care sector (Medical/Nursing Services), PRVA carries a Roarable D+ (53/100 RQD), trailing P/E of 122.6x, gross margin of —, and ROIC of 10.5%. By comparison, AVAH (Aveanna Healthcare Holdings Inc.) holds a C grade (65/100 RQD, P/E N/A, ROIC 15.7%, cap $2.87B) and ADUS (Addus HomeCare Corporation) posts a B grade (74/100 RQD, P/E 24.2x, ROIC 9.1%, cap $2.34B). Among the 5-stock peer group, OPCH leads on earnings multiple (23.0x) while AVAH leads on capital efficiency (15.7% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for PRVA?
▼

Per PRVA's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001759655), Privia Health Group Inc. generated $95.9M in revenue (+101.6% YoY), $22.9M in net income, and $163.4M in free cash flow against $1.37B in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $21.20 (-0.36%)🧬 Cannibal Buyback (-0.68% YoY Shares)⚙️ Cash Engine: 14/20 (B-) • 170.5% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 53/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.9% avg 90D alpha vs SPY • 50.6% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →
RQD QUANT TACHOMETERSELL / AVOID • D+
025507510053
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk D+
Cash (14)Whales (7)SEC (13)Macro (9)CEO (10)
Each axis scored 0–20
12M PRICE TARGET CONE-2.3% Base Target
$30 Bull$21 Base$16 Bear
📬 FREE PRVA RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for PRVA)Realized 20D OHLCV Swing Band: ±5.8%
Deterministic 5-Pillar Attribution (53/100 Composite)
🔍 WHY PRVA SCORES 53/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Cash Engine Quality+14/20 pts (26% of score)

SEC XBRL FY 2025 (10-K): 170.5% FCF Margin ($163.4M FCF) & 52% Gross Margin

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (25% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 6/9

▼ #1 Drag / Risk Factor: Whale & Options Positioning7/20 pts (-13 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-13 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
61
Grade C$21.65+5.9% Next Q
Q2 (-2Q)
58
Grade C$22.93-4.8% Next Q
Q3 (-1Q)
56
Grade C$21.83-2.5% Next Q
Current
53
Grade D+$21.28-0.9% Hist 90D α
Trajectory: C (61) → D+ (53)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a PRVA Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While PRVA currently carries a cautious 53/100 (D+) rating due to Whale & Options Positioning (7/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($20.91) and Max Pain ($22.34) forces dealer call-delta covering toward $30.26.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Cannibal Buyback (-0.68% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $PRVA• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “PRVA Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
YES 53%NO 47%Trade / Inspect Odds →
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →

Why PRVA Stock slipped -0.93% Today — RQD Quant Desk Flash

Privia Health Group Inc. (PRVA) slipped -0.93% to $21.28, trading at 24% of its 52-week range ($18.92 – $28.82). Stretched risk/reward at 123x P/E (11% return on capital) under elevated 10-year interest-rate pressure.

  • ▸Technical Tape: Trading at 24% of its 52-week range ($18.92 – $28.82) with RSI-14 at 48.8 (NEUTRAL RANGE).
  • ▸Volatility Profile: Historical 20-day realized swing band of ±5.8% around $21.28 (no active unusual options sweep snapshot on file).
  • ▸Fundamental Anchor: Roarable D+ (Sell) backed by 52% gross margin and $163.4M annual free cash flow.
Live PRVA Headlines & Catalysts
CATALYSTYahoo • 15d ago
2 Profitable Stocks for Long-Term Investors and 1 We Ignore

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring PRVA)

  • ✓Walkthrough of PRVA's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
PRVA // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -12.21%▼ DESCENDING CHANNEL
2026-11-03O $21.99H $21.99L $21.28C $21.28VOL 841.2K
RES: $22.38SUP: $18.28SMA50: $20.91SMA200: $22.65
$29.51$26.64$23.77$20.90$18.03RES $22.38SUP $18.28$21.282026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

PRVA Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 PRVA Butterfly Map → + Track PRVA →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
48.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on PRVA today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for PRVA. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for PRVA today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (PRVA)

Health Care Rank #230 of 1016 ⚔️ AVAH vs PRVA Full Matrix →

1. Head-to-Head Health Care Peer Comparison (PRVA vs. AVAH, ADUS, WGS, OPCH)

Industry: Medical/Nursing Services (29 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Privia Health Group Inc. (PRVA) ranks #230 by composite RQD confidence (53/100, grade D+) and #215 by equity capitalization ($2.74B). Within this direct 5-issuer industry benchmark cohort, OPCH leads on earnings valuation at 23.0x trailing P/E, while AVAH leads on capital efficiency and profitability with 15.7% ROIC and 33.3% gross margin. ADUS currently holds the highest overall quantitative score in the immediate peer group at 74/100 (B) compared with PRVA at 53/100 (D+).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
PRVA ACTIVE
Privia Health Group Inc.
D+ 53/100 122.6x — 10.5% -0.93% $2.74B Benchmark Subject
AVAH
Aveanna Healthcare Holdings Inc.
C 65/100 — 33.3% 15.7% -0.30% $2.87B /avah-vs-prva →
ADUS
Addus HomeCare Corporation
B 74/100 24.2x 32.5% 9.1% +0.17% $2.34B /adus-vs-prva →
WGS
GeneDx Holdings Corp. (Class A)
D 47/100 — 69.7% -4.1% -7.20% $2.06B /wgs-vs-prva →
OPCH
Option Care Health Inc.
B 74/100 23.0x 19.3% 11.9% -0.44% $4.77B /opch-vs-prva →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001759655

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Privia Health Group Inc. (PRVA) reported GAAP revenue of $95.9M (+101.6% vs. FY2024 revenue of $47.5M , and +65.8% cumulative change since FY2023) , GAAP net income of $22.9M, operating cash flow of $163.4M, and free cash flow of $163.4M (+49.5% YoY). On the balance sheet, PRVA closed FY2025 with $1.37B in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 6/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $95.9M $22.9M $163.4M $163.4M $1.37B —
FY2024 (FY) 2024-12-31 $47.5M $14.4M $109.3M $109.3M $1.14B —
FY2023 (FY) 2023-12-31 $57.8M $23.1M $80.8M $80.8M — —

3. PRVA Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is PRVA stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Privia Health Group Inc. (NASDAQ: PRVA) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 53/100 at a spot price of $21.28 (-0.93% 1D, market cap $2.74B). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 10/20. Across 1016 tracked Health Care issuers, PRVA ranks #230 in composite RQD confidence.

How does PRVA compare to AVAH and ADUS in the Health Care sector?

Within the Health Care sector (Medical/Nursing Services), PRVA carries a Roarable D+ (53/100 RQD), trailing P/E of 122.6x, gross margin of —, and ROIC of 10.5%. By comparison, AVAH (Aveanna Healthcare Holdings Inc.) holds a C grade (65/100 RQD, P/E N/A, ROIC 15.7%, cap $2.87B) and ADUS (Addus HomeCare Corporation) posts a B grade (74/100 RQD, P/E 24.2x, ROIC 9.1%, cap $2.34B). Among the 5-stock peer group, OPCH leads on earnings multiple (23.0x) while AVAH leads on capital efficiency (15.7% ROIC).

What are the biggest fundamental strengths and SEC risk factors for PRVA?

Per PRVA's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001759655), Privia Health Group Inc. generated $95.9M in revenue (+101.6% YoY), $22.9M in net income, and $163.4M in free cash flow against $1.37B in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is PRVA trading relative to its 50-day, 200-day, and 52-week technical levels?

PRVA last traded at $21.28 (-0.93% on volume of 1,164,683 shares), positioning the stock +1.77% above its 50-day simple moving average ($20.91) and -6.05% below its 200-day simple moving average ($22.65). Across its 52-week range of $18.92 to $28.82, PRVA sits at the 23.8% percentile with a 14-day RSI of 48.8 (NEUTRAL RANGE) and an implied next-earnings move of ±5.8% ($20.05 to $22.51).

Direct Sub-Reports: PRVA RQD Cockpit PRVA 12M Forecast PRVA Earnings & Move PRVA Dividends & DRIP PRVA Insiders & 13F PRVA Whale Options PRVA Profit Sankey PRVA News & Why
ROARABLE RATING BRIEF • RQD 53/100 (D+) ✓ SEC XBRL & RQD VERIFIED

PRVA — Privia Health Group Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Privia Health Group Inc. (PRVA) earns a live Roarable RQD composite score of 53/100, corresponding to a D+ letter grade (Roarable Sell) at a spot price of $21.28 (-0.93% 1D, market capitalization $2.74B).

  • Fundamental Cash Engine (14/20): Anchored by return on invested capital (ROIC) of 10.5%, gross margin of —, operating margin of —, and free cash flow yield of 5.82%.
  • Whale 13F & Options Flow (7/20) + Insider Conviction (13/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (9/20) + Forensic Balance Sheet (10/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 6/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Privia Health Group Inc. (PRVA) is a NASDAQ-listed operating company in the Medical/Nursing Services industry (Health Care sector) with an equity market capitalization of $2.74B. The business operates with a gross margin of 0%, an operating margin of 0%, and a return on invested capital (ROIC) of 10.5% (free cash flow yield of 5.82%). Within the Medical/Nursing Services peer group, investor evaluation centers on operating leverage, unit margin durability, and capital allocation efficiency across market cycles.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Privia Health Group Inc. (PRVA) reported $95.9M in annual revenue (up from $47.5M in FY2024, +101.6% YoY) and $22.9M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($57.8M revenue, $23.1M net income) through FY2025, PRVA scaled operating cash flow to $163.4M and free cash flow to $163.4M, backed by $1.37B in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (D+ • RQD 53/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of 5.82% and institutional whale pillar of 7/20. With Fundamental Cash Engine at 14/20 and Institutional Whale Flow at 7/20, sustained execution supports upside toward the upper end of the $18.92 – $28.82 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh 122.6x trailing P/E and 68.1x EV/EBITDA against — operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Operating in Medical/Nursing Services (Health Care), PRVA carries a macro regime beta of 1.00 and gross margin of —.

  • Key Question #1: Can PRVA sustain or expand its — operating margin and 10.5% ROIC against Medical/Nursing Services peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $95.9M and free cash flow of $163.4M, how will capital allocation balance growth reinvestment against $0 in total debt?
  • Key Question #3: How sensitive is PRVA's 114.0x forward P/E multiple to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

PRVA Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Privia Health Group Inc. (PRVA) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to PRVA Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

PRVA Bull vs. Bear Conversation Board — What's Your Call at $21.28?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON PRVA 🐻 33% BEARISH CONVICTION
1. Pick Your Side on PRVA:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
BR BreakoutHunter RQD DEBATE OPENER • Swing & Catalyst Trader 🐂 BULLISH 🎯 Target: $28.35 (+32.0%)
📌 Pinned Debate

A 5.82% FCF yield and $163.4M FY 2025 free cash flow support the cash engine pillar (14/20).

Long PRVA at $21.48 targeting $28.35. A 5.82% FCF yield and $163.4M FY 2025 free cash flow support the cash engine pillar (14/20).. Institutional whale score is 7/20 and the risk/reward vs. the $18.92 52-week low is skewed heavily in favor of bulls.

EarningsSniper 🐂 BULL

@MultipleCompression Shorting a 7/20 institutional whale-flow stock at $21.48 is dangerous when funds are rotating into Health Care.

MU MultipleCompression RQD DEBATE OPENER • Valuation Discipline 🐻 BEARISH 🎯 Target: $16.11 (-25.0%)
Spot @ $21.48

A P/E (TTM) of 122.6 and EV/EBITDA of 68.1 leave the valuation stretched against reported EPS of 0.18.

I respect the product at Privia Health Group Inc., but the stock at $21.48 is a different story. A P/E (TTM) of 122.6 and EV/EBITDA of 68.1 leave the valuation stretched against reported EPS of 0.18.. FCF yield is 5.82% and RQD sits at 53/100 (D+) — why pay up here when you can wait for next quarter's numbers?

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%